Progenics Pharmaceuticals, Inc. (PGNX) CEO, Mark R. Baker, To Present At 13th Annual Needham Healthcare Conference
4/8/2014 7:50:34 AM
TARRYTOWN, N.Y., April 7, 2014 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX), an oncology company focused on the development of innovative approaches to targeting and treating cancer, announced today that Mark R. Baker, CEO, will present at the 13th Annual Needham Healthcare Conference to be held April 8th and 9th at the Westin Grand Central Hotel in New York City. The presentation will take place on Tuesday, April 8th at 10:00 AM EST.
Help employers find you! Check out all the jobs and post your resume.
comments powered by